9-128722556-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000372663.9(ZDHHC12):āc.119A>Gā(p.Glu40Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00051 in 1,592,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000372663.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZDHHC12 | NM_032799.5 | c.119A>G | p.Glu40Gly | missense_variant | 2/5 | ENST00000372663.9 | NP_116188.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZDHHC12 | ENST00000372663.9 | c.119A>G | p.Glu40Gly | missense_variant | 2/5 | 1 | NM_032799.5 | ENSP00000361748.4 |
Frequencies
GnomAD3 genomes AF: 0.000474 AC: 72AN: 151970Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000274 AC: 59AN: 215310Hom.: 0 AF XY: 0.000285 AC XY: 33AN XY: 115766
GnomAD4 exome AF: 0.000514 AC: 741AN: 1440730Hom.: 0 Cov.: 31 AF XY: 0.000490 AC XY: 350AN XY: 714450
GnomAD4 genome AF: 0.000473 AC: 72AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | The c.119A>G (p.E40G) alteration is located in exon 2 (coding exon 2) of the ZDHHC12 gene. This alteration results from a A to G substitution at nucleotide position 119, causing the glutamic acid (E) at amino acid position 40 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at